Search

everythinglearnresearchcommunity

for

Search:↓

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Bazhengsan reduces inflammation and tissue growth in chronic prostatitis.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

CRET therapy affects inflammation in skin cells by changing cytokine levels and activating certain proteins.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

PRP may help reduce brain inflammation and protect brain cells.

Fenugreek extract may help treat benign prostatic hyperplasia.

Dermal factors are crucial in regulating melanin production in skin.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

Ustekinumab effectively treated psoriasis and ulcerative colitis in a teen after infliximab caused complications.

A woman with inflammatory bowel disease improved after treatment with ustekinumab for a rare skin condition associated with her disease.

Tannic acid helps wounds heal faster in rats by activating certain cell signals and reducing inflammation.

Psoriatic alopecia is a challenging hair loss condition linked to psoriasis, needing better diagnosis and personalized treatments.

Ficus carica leaf extract may help treat skin disorders by reducing inflammation and androgen effects in skin cells.

FGF21 can help reduce skin inflammation caused by C. acnes.

Higher levels of IL-17A and IL-2 are linked to alopecia areata.

ILC1 cells contribute to hair loss in alopecia areata.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Targeted therapy with Ustekinumab significantly improved a skin condition called ILVEN, which is caused by mutations in the CARD14 gene.

Women with PCOS, especially those overweight, have higher levels of IL-18 in their endometrium, which may affect fertility.

COVID-19 may cause hair loss and scalp pain due to inflammation and changes in hair follicle receptors, but these symptoms typically resolve in 2 to 4 months.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.